0.5105  0.046 (10%)		03-12 16:00
Open: 0.48 High: 0.56 Volume: 7,754,711		Pre. Close: 0.4641 Low: 0.4151 Market Cap: 8(M)

Short term
Mid term
Targets	6-month :	0.75	1-year :	0.87
Resists	First :	0.64	Second :	0.75
Pivot price	0.41
Supports	First :	0.47	Second :	0.37
MAs	MA(5) :	0.42	MA(20) :	0.41
	MA(100) :	0.58	MA(250) :	0.95
MACD	MACD :	-0.1	Signal :	-0.1
%K %D	K(14,3) :	33.6	D(3) :	24.9
RSI	RSI(14): 64.1
52-week	High :	3.17	Low :	0.37

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
[ SCNX ] has closed above the upper band by 18.3%. If price is in a uptrend band; this upward trend in price might continue. However a short term pullback inside the band is likely.Bollinger Bands are 69% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 79 bars. This is a sign that the market may be about to initiate a new trend.

If tomorrow:	Open lower	Open higher
High:	0.56 - 0.56	0.56 - 0.57
Low:	0.41 - 0.41	0.41 - 0.41
Close:	0.51 - 0.51	0.51 - 0.51

TRxADE HEALTH, Inc. operates as health services IT company. It offers an online web-based buying and selling platform for licensed pharmaceutical wholesalers to sell brand, generic, and non-drug products and services to government organizations, hospitals, clinics and independent pharmacies. TRxADE HEALTH, Inc. is headquartered in Tampa, Florida.

Wed, 11 Mar 2026
Why Is Scienture Holdings Stock (SCNX) Up Today? - TipRanks

Wed, 11 Mar 2026
SCIENTURE Broadens Commercial Access for REZENOPY, Highest-Dose FDA-Approved Naloxone Nasal Spray, Through GPO Agreements Reaching Over 5,000 U.S. Institutions - Bitget

Wed, 11 Mar 2026
High-dose overdose spray REZENOPY set to reach 5,000 US care sites - Stock Titan

Wed, 11 Mar 2026
EXCLUSIVE: Scienture Expands Reach For Opioid Overdose Treatment, With Deals Covering 60% Of US Institutional Market - Benzinga

Tue, 24 Feb 2026
Maxim Group Initiates Coverage of Scienture Holdings (SCNX) with Buy Recommendation - Nasdaq

Wed, 14 Jan 2026
SCNX - Scienture Holdings, Inc Latest Stock News & Market Updates - Stock Titan

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Outperform
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Underperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Underperform
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Underperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Underperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Neutral

Exchange: NASDAQ
Sector: Healthcare
Industry: Medical - Healthcare Information Services
Shares Out	41 (M)
Shares Float	34 (M)
Held by Insiders	16.8 (%)
Held by Institutions	3.7 (%)
Shares Short	2,370 (K)
Shares Short P.Month	3,500 (K)

EPS	0.75
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	3.56
Profit Margin	0 %
Operating Margin	-739.2 %
Return on Assets (ttm)	-10.9 %
Return on Equity (ttm)	-24.1 %
Qtrly Rev. Growth	809.7 %
Gross Profit (p.s.)	0.01
Sales Per Share	0.01
EBITDA (p.s.)	-0.43
Qtrly Earnings Growth	0 %
Operating Cash Flow	-11 (M)
Levered Free Cash Flow	2 (M)

PE Ratio	0.68
PEG Ratio	0
Price to Book value	0.14
Price to Sales	31.74
Price to Cash Flow	-1.87

Dividend	1.5
Forward Dividend	0
Dividend Yield	293.8%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.